Diabetes Mellitus Review.
Diabetes mellitus is a group of physiological dysfunctions characterized by hyperglycemia resulting directly from insulin resistance, inadequate insulin secretion, or excessive glucagon secretion. Type 1 diabetes (T1D) is an autoimmune disorder leading to the destruction of pancreatic beta-cells. Type 2 diabetes (T2D), which is much more common, is primarily a problem of progressively impaired glucose regulation due to a combination of dysfunctional pancreatic beta cells and insulin resistance. The purpose of this article is to review the basic science of type 2 diabetes and its complications, and to discuss the most recent treatment guidelines.
Meg
M
Blair
D057911:Angiotensin Receptor Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D015190:Blood Glucose Self-Monitoring; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis / Q000628:therapy*; D003928:Diabetic Nephropathies / Q000209:etiology / Q000628:therapy*; D003929:Diabetic Neuropathies / Q000209:etiology / Q000628:therapy*; D003930:Diabetic Retinopathy / Q000209:etiology / Q000628:therapy*; D003927:Diet, Diabetic; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D009043:Motor Activity; D064647:Nephrology Nursing
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D007004:Hypoglycemic Agents